Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)

C. Mathieu, A. H. Barnett, H. Brath, I. Conget, J. J. de Castro, R. Goeke, E. Marquez Rodriguez, P. M. Nilsson, E. Pagkalos, A. Penfornis, N. C. Schaper, S. K. Wangnoo, W. Kothny, G. Bader

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)947-956
JournalInternational Journal of Clinical Practice
Issue number10
Publication statusPublished - Oct 2013

Cite this